OTC Pain

GRAND RAPIDS, Mich. — Meijer and Spectrum Health today announced they have collaborated to launch a line of co-branded over-the-counter products.

“As the nation’s ninth largest grocery retailer, Meijer has an undeniable presence throughout the Midwest,” Spectrum Health SVP and chief strategy officer Roger Jansen said. “We are excited to work with Meijer. This collaboration enables Spectrum Health to meet consumers where they are on their health-and-wellness journey.”

URBANDALE, Iowa — Spotlight Innovation on Monday announced that its subsidiary Caretta Therapeutics' new over-the-counter chronic pain relief product, Venodol roll-on, is now available for pre-order in the U.S. on the company's web site.

There’s a global race right now to become the global drug chain leader. It brings three very different things together: the board game Risk, an iceberg and a Bob Dylan song. I’ll explain.

MADRID — The latest published evidence on osteoarthritis treatment was presented Wednesday at the symposium organized by Bioiberica and IBSA at the Annual European Congress of Rheumatology, here.

A new clinical trial, carried out by IBSA and called CONCEPT (ChONdroitin vs CElecoxib vs Placebo Trial), shows that pharmaceutical grade chondroitin sulfate is as effective as an anti-inflammatory drug (celecoxib) and superior to placebo for pain reduction and improvement of functional disability in patients with knee osteoarthritis.

In April, Drug Store News and Mack Elevation co-hosted the third annual New General Market Summit. The one-day thought leadership event examined the changing face of the American shopper — driven not only by the growth of multicultural and millennial consumers but also by the influence these consumers are having on all consumers — and how the best brands are able to connect on an emotional level, as well as build community and advocacy with an ever-more diverse consumer.